Inhibitory effect of Galgeun-tang on RANKL-induced osteoclast differentiation and bone loss in ovariectomized rats

Biotechnology and Bioprocess Engineering

Volumn 16, Issue 1, 2011, Pages 158-166

  Shim, Ki Shuk ^a   Park, Hwayong ^a   Lee, Ji Hye ^a   Ma, Choong Je ^a   Choi, Sung Up ^a   Lee, Jae Hoon ^a   Ma, Jin Yeul ^a,b  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

Bone mineral density; Galgeun tang; Osteoclast differentiation; Ovariectomy; RAW264.7 cells

Indexed keywords

BIFIDOBACTERIUM; BODY WEIGHT; BONE LOSS; BONE MINERAL DENSITY; CEREBRAL CIRCULATION; GALGEUN-TANG; HIGH-DENSITY LIPOPROTEINS; INHIBITORY EFFECT; LIPID CONTENT; LOW DENSITY LIPOPROTEINS; MRNA EXPRESSION LEVEL; NUCLEAR FACTORS; OSTEOCLAST DIFFERENTIATION; OVARIECTOMY; RECEPTOR ACTIVATOR; SERUM CHOLESTEROL; TARTRATE-RESISTANT ACID PHOSPHATASE; TRIGLYCERIDE LEVELS;

ANTHROPOMETRY; BODY FLUIDS; BONE; CHOLESTEROL; GYNECOLOGY; PHOSPHATASES; SILICATE MINERALS;

RATS;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCIUM; CHOLESTEROL; GALGEUN TANG; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM BREVE; BONE DENSITY; C SRC GENE; CALCIUM BLOOD LEVEL; CATHEPSIN K GENE; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; ORGAN WEIGHT; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PHOSPHATE BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; RAT; TARTRATE RESISTANT ACID PHOSPHATASE GENE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WEIGHT REDUCTION;

BIFIDOBACTERIUM BREVE; RATTUS;

EID: 84863015733     PISSN: 12268372     EISSN: 19763816     Source Type: Journal    
DOI: 10.1007/s12257-010-0178-9     Document Type: Article

References (34)

1. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345-357. (Pubitemid 30649812)
2. Rodan, G. A. and T. J. Martin (2000) Therapeutic approaches to bone diseases. Science 289:1508-1514.
3. Teitelbaum, S. L. (2000) Bone resorption by osteoclasts. Science 289:1504-1508.
4. Boyle, W. J., W. S. Simonet, and D. L. Lacey (2003) Osteoclast differentiation and activation. Nature 423:337-342. (Pubitemid 40852708)
5. Putnam, S. E., A. M. Scutt, K. Bicknell, C. M. Priestley, and E. M. Williamson (2007) Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 21:99-112.
6. Rechner, A. R., G. Kuhnle, P. Bremner, G. P. Hubbard, K. P. Moore, and C. A. Rice-Evans (2002) The metabolic fate of dietary polyphenols in humans. Free Radic. Biol. Med. 33:220-235. (Pubitemid 34775194)
7. Scholz-Ahrens, K. E., P. Ade, B. Marten, P. Weber, W. Timm, Y. Açil, C. C. Glüer, and J. Schrezenmeir (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J. Nutr. 137:838-846.
8. Toda, T., T. Uesugi, K. Hirai, H. Nukaya, K. Tsuji, and H. Ishida (1999) New 6-O-acyl isoflavone glycosides from soybeans fermented with Bacillus subtilis (natto). I. 6-O-succinylated isoflavone glycosides and their preventive effects on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol. Pharm. Bull. 22:1193-1201. (Pubitemid 30004197)
9. Chonan, O., K. Matsumoto, and M. Watanuki (1995) Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 59:236-239.
10. Heo, J. (1984) Donguibogam. pp. 670. Namsadang Press, Seoul, Korea.
11. Lyu, S. A., S. Y. Lee, S. J. Lee, S. W. Son, M. O. Kim, G. Y. Kim, Y. H. Kim, H. J. Yoon, H. Kim, D. I. Park, and W. S. Ko (2006) Seungma-galgeun-tang attenuates proinflammatory activities through the inhibition of NF-kappaB signal pathway in the BV-2 microglial cells. J. Ethnopharmacol. 107:59-66. (Pubitemid 44038811)
12. Shin, J. M., Y. O. Kim, and S. H. Baek (2008) Free radical scavenging activity and kinetic behavior of the Galgeuntang water extract. Orient. Pharm. Exp. Med. 8:32-38.
13. Song, J., Q. Han, C. Qiao, Y. Yip, and H. Xu (2007) Simultaneous determination of multiple marker constituents in concentrated Gegen Tang granule by high performance liquid chromatography. Chin. Med. 2:7.
14. Hsu, H., D. L. Lacey, C. R. Dunstan, I. Solovyev, A. Colombero, E. Timms, H. L. Tan, G. Elliott, M. J. Kelley, I. Sarosi, L. Wang, X. Z. Xia, R. Elliott, L. Chiu, T. Black, S. Scully, C. Capparelli, S. Morony, G. Shimamoto, M. B. Bass, and W. J. Boyle (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Nat. Acad. Sci. 96:3540-3545. (Pubitemid 29168945)
15. Kalu, D. N. (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15:175-191.
16. Lelovas, P. P., T. T. Xanthos, S. E. Thoma, G. P. Lyritis, and I. A. Dontas (2008) The laboratory rat as an animal model for osteoporosis research. Comp. Med. 58:424-430.
17. Rozen, S. and H. J. Skaletsky (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
18. -ΔΔCT method. Methods 25:402-408. (Pubitemid 34164012)
19. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama, and T. Taniguchi (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell. 3:889-901. (Pubitemid 35460788)
20. Ikeda, F., R. Nishimura, T. Matsubara, S. Tanaka, J. Inoue, S. V. Reddy, K. Hata, K. Yamashita, T. Hiraga, T. Watanabe, T. Kukita, K. Yoshioka, A. Rao, and T. Yoneda (2004) Critical roles of c-Jun. signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114:475-484. (Pubitemid 39572097)
21. Pang, M., A. F. Martinez, I. Fernandez, W. Balkan, and B. R. Troen (2007) AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene 15:151-158. (Pubitemid 47488713)
22. Halleen, J. M., S. Raisanen, J. J. Salo, S. V. Reddy, G. D. Roodman, T. A. Hentunen, P. P. Lehenkari, H. Kaija, P. Vihko, and H. K. Vaananen (1999) Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J. Biol. Chem. 274:22907-22910.
23. Saftig, P., E. Hunziker, V. Everts, S. Jones, A. Boyde, O. Wehmeyer, A. Suter, and K. von Figura (2000) Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv. Exp. Med. Biol. 477:293-303. (Pubitemid 32174016)
24. Soriano, P., C. Montgomery, R. Geske, and A. Bradley (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702. (Pubitemid 121001157)
25. Sung, B., A. Murakami, B. O. Oyajobi, and B. B. Aggarwal (2009) Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice. Cancer Res. 69:1477-1484.
26. Tsuji-Naito, K. (2008) Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Bioorg. Med. Chem. 16:9176-9183.
27. Qin, L., T. Han, Q. Zhang, D. Cao, H. Nian, K. Rahman, and H. Zheng (2008) Antiosteoporotic chemical constituents from Er-Xian Decoction, a traditional Chinese herbal formula. J. Ethnopharmacol. 118:271-279.
28. Tsai, H. Y., H. Y. Lin, Y. C. Fong, J. B. Wu, Y. F. Chen, M. Tsuzuki, and C. H. Tang (2008) Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Eur. J. Pharmacol. 588:124-133.
29. Zhang, Y., X. Zeng, L. Zhang, and X. Zheng (2007) Stimulatory effect of puerarin on bone formation through activation of PI3K/Akt pathway in rat calvaria osteoblasts. Planta Med. 73:341-347. (Pubitemid 46910416)
30. Yen, P. H., P. V. Kiem, N. X. Nhiem, N. H. Tung, T. H. Quang, C. V. Minh, J. W. Kim, E. M. Choi, and Y. H. Kim (2007) A new monoterpene glycoside from the roots of Paeonia lactiflora increases the differentiation of osteoblastic MC3T3-E1 cells. Arch. Pharm. Res. 30:1179-1185.
31. Aoki, F., S. Honda, H. Kishida, M. Kitano, N. Arai, H. Tanaka, S. Yokota, K. Nakagawa, T. Asakura, Y. Nakai, and T. Mae (2007) Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci. Biotechnol. Biochem. 71:206-214. (Pubitemid 46155164)
32. Wang, J. F., Y. X. Guo, J. Z. Niu, J. Liu, L. Q. Wang, and P. H. Li (2004) Effects of Radix Puerariae flavones on liver lipid metabolism in ovariectomized rats. World J. Gastroenterol. 10:1967-1970. (Pubitemid 39029304)
33. Martin, P. M., K. B. Horwitz, D. S. Ryan, and W. L. McGuire (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinol. 103:1860-1867. (Pubitemid 9052644)
34. Bolego, C., A. Poli, A. Cignarella, and R. Paoletti (2003) Phytoestrogens: Pharmacological and therapeutic perspectives. Curr. Drug Targets 4:77-87. (Pubitemid 36131643)